Treatment and secondary prevention of venous thromboembolism in cancer patients

G. A. Shakaryants, D. A. Budanova, K. V. Lobastov, N. V. Khabarova, Yu. Yu. Kirichenko, Yu. N. Belenkov
2020 Kardiologiâ  
Oncological patients are a high-risk group for venous thromboembolic complications. These complications significantly impair the outcome of antitumor treatment and take a leading place in the structure of mortality. Treatment of venous thromboembolic complications in oncological patients is a serious challenge. When selecting an anticoagulant, the physician should consider its efficacy and safety and possible drug interactions. Based on results of multiple studies presented in this article,
more » ... n this article, physicians will be able to choose an optimum therapeutic tactics and secondary prevention of thromboembolic complications for this group of patients.
doi:10.18087/cardio.2020.3.n904 pmid:32375618 fatcat:k3f34xgajrdzrgtmeg7jowvbcy